Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
Funding to advance HIV/AIDS research in hearing, balance, taste, smell, voice, speech, and language within NIDCD's mission, prioritizing OAR's research areas.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health
Due Dates: May 7, 2025 | September 7, 2025 | January 7, 2026 | May 7, 2026 | June 16, 2026 | July 16, 2026 | October 16, 2026 | February 16, 2027 | June 16, 2027 | October 16, 2027
Funding Amounts: Up to $275,000 in direct costs over 2 years; no more than $200,000 in any single year.
Summary: Supports exploratory/developmental research on HIV/AIDS within the NIDCD mission areas (hearing, balance, taste, smell, voice, speech, language), including optional low-risk clinical trials.
Key Information: Only low risk clinical trials are allowed; see FOA for restrictions.
Description
This opportunity supports research that advances understanding of HIV/AIDS as it relates to the mission areas of the National Institute on Deafness and Other Communication Disorders (NIDCD): hearing, balance, taste, smell, voice, speech, and language. The program encourages hypothesis-driven basic, translational, clinical, and epidemiological research, including multidisciplinary collaborations between investigators in communication disorders and HIV/AIDS. Projects may include studies on the impact of HIV infection and therapies on communication functions, development of prevention or treatment strategies for comorbid communication disorders in people living with HIV, and leveraging existing HIV/AIDS cohorts or clinical infrastructure. Only low-risk clinical trials are permitted under this announcement.
